SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-09-29
👔
UNITED THERAPEUTICS Corp
@UTHR_InsiderForm 4 Filing: ROTHBLATT MARTINE A Exercises Options for $5.7M of $UTHR
OPTION EXERCISE
⚡ MATERIALITY: 7/10
corporate issuer
UNITED THERAPEUTICS Corp
Ticker: $UTHR
Transaction Value
$5.7M
Price/Share: $299.31
transaction date
2026-09-28
Shares: 19,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, ROTHBLATT MARTINE A, holds the title of Chairperson & CEO at UNITED THERAPEUTICS Corp.
On 2026-09-28, the insider transacted 19,000 shares.The shares were transacted at a weighted average price of $299.31 per share, resulting in a total market-relevant value of $5.7M.
Executive Summary Summary
ROTHBLATT MARTINE A (Chairperson & CEO) exercised options for $5.7M of $UTHR
Post-Transaction Position: 333,943 shares
SEC Accession No: 0001106578-26-000151 (CIK: 1106578)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.